[go: up one dir, main page]

MX2017013564A - Formulaciones de glucopiranosil lipido a y alérgenos de cacahuete para administración sublingual. - Google Patents

Formulaciones de glucopiranosil lipido a y alérgenos de cacahuete para administración sublingual.

Info

Publication number
MX2017013564A
MX2017013564A MX2017013564A MX2017013564A MX2017013564A MX 2017013564 A MX2017013564 A MX 2017013564A MX 2017013564 A MX2017013564 A MX 2017013564A MX 2017013564 A MX2017013564 A MX 2017013564A MX 2017013564 A MX2017013564 A MX 2017013564A
Authority
MX
Mexico
Prior art keywords
glucopyranosyl lipid
peanut allergen
sublingual administration
allergen formulations
peanut
Prior art date
Application number
MX2017013564A
Other languages
English (en)
Inventor
HO Chris
Calichiama Pierre
He Yan
Arigon Jerome
Demontigny Pierre
Haddad El-Bdaoui
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of MX2017013564A publication Critical patent/MX2017013564A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/577—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente solicitud se refiere a composiciones y métodos para tratar alergia, por ejemplo, alergia al cacahuete, en pacientes. Los métodos implican administrar adyuvante glucopiranosil lípido (GLA) y alergeno(s) del cacahuete al paciente vía una ruta sublingual.
MX2017013564A 2015-04-23 2016-04-22 Formulaciones de glucopiranosil lipido a y alérgenos de cacahuete para administración sublingual. MX2017013564A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562151922P 2015-04-23 2015-04-23
US201562194067P 2015-07-17 2015-07-17
US201662303224P 2016-03-03 2016-03-03
EP16305344 2016-03-24
PCT/US2016/028890 WO2016172511A1 (en) 2015-04-23 2016-04-22 Glucopyranosyl lipid a and peanut allergen formulations for sublingual administration

Publications (1)

Publication Number Publication Date
MX2017013564A true MX2017013564A (es) 2018-04-26

Family

ID=55699581

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017013564A MX2017013564A (es) 2015-04-23 2016-04-22 Formulaciones de glucopiranosil lipido a y alérgenos de cacahuete para administración sublingual.

Country Status (12)

Country Link
US (1) US20160310589A1 (es)
EP (1) EP3285740A1 (es)
JP (1) JP2018516867A (es)
KR (1) KR20170139130A (es)
CN (1) CN107847439A (es)
AU (1) AU2016252857A1 (es)
BR (1) BR112017022755A2 (es)
CA (1) CA2983437A1 (es)
MX (1) MX2017013564A (es)
SG (1) SG11201708590PA (es)
TW (1) TW201709926A (es)
WO (1) WO2016172511A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR102017026619A2 (pt) * 2017-02-15 2018-10-30 Euroimmun Medizinische Labordiagnostika Ag ensaio melhorado para a diagnose de alergia a amendoim
EP3244212A1 (en) * 2017-02-15 2017-11-15 Euroimmun Medizinische Labordiagnostika AG An improved assay for the diagnosis of peanut allergy
CN110520214B (zh) 2017-04-13 2023-03-21 国立大学法人北海道大学 使用流路构造体的脂质粒子或微胞的形成方法
WO2019189676A1 (ja) * 2018-03-30 2019-10-03 学校法人 川崎学園 ヒアルロン酸を有効成分として含むアレルゲン作用増強剤
AU2022256497A1 (en) * 2021-04-16 2023-11-30 Cour Pharmaceuticals Development Company Inc. Treatment of peanut allergy with tolerizing nanoparticles
AU2023253754A1 (en) 2022-04-11 2024-10-17 Alk-Abelló A/S Peanut allergen composition

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4912094B1 (en) * 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
AU729836B2 (en) 1995-12-29 2001-02-08 University Of Arkansas, The Peanut allergens and methods
US20060002959A1 (en) * 1996-11-14 2006-01-05 Government Of The United States Skin-sctive adjuvants for transcutaneous immuization
CA2366688A1 (en) * 1999-02-26 2000-08-31 Chiron Corporation Use of bioadhesives and adjuvants for the mucosal delivery of antigens
GB0000891D0 (en) * 2000-01-14 2000-03-08 Allergy Therapeutics Ltd Formulation
EP2324850A1 (en) * 2005-10-04 2011-05-25 Alk-Abelló A/S Solid vaccine formulation
CA2628226A1 (en) * 2005-11-04 2007-05-10 Alk-Abello A/S Use of a liquid allergy vaccine formulation for oromucosal administration
ITMI20061117A1 (it) * 2006-06-09 2007-12-10 Michele Bonanomi Una composizione farmaceutica per la somministrazione sublinguale di vaccini metodo per la sua preparazione e sui usi
EP2486938B1 (en) * 2006-09-26 2018-05-09 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
US20090181078A1 (en) * 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
WO2009035528A2 (en) 2007-09-07 2009-03-19 University Of Georgia Research Foundation, Inc. Synthetic lipid a derivative
WO2013087119A1 (en) 2011-12-16 2013-06-20 Hal Allergy Holding B.V. Pharmaceutical formulations and the use thereof for the treatment of peanut allergy
WO2013173697A1 (en) * 2012-05-17 2013-11-21 The Johns Hopkins University Orally dissolving thin films containing allergens and methods of making and use
DK3482771T3 (da) * 2013-03-14 2023-03-20 Nestle Sa Fremstilling af jordnøddeformuleringer til oral desensibilisering

Also Published As

Publication number Publication date
WO2016172511A1 (en) 2016-10-27
CA2983437A1 (en) 2016-10-27
EP3285740A1 (en) 2018-02-28
KR20170139130A (ko) 2017-12-18
BR112017022755A2 (pt) 2018-07-17
JP2018516867A (ja) 2018-06-28
SG11201708590PA (en) 2017-11-29
AU2016252857A1 (en) 2017-12-07
CN107847439A (zh) 2018-03-27
US20160310589A1 (en) 2016-10-27
TW201709926A (zh) 2017-03-16

Similar Documents

Publication Publication Date Title
MX2024013963A (es) Un antagonista de il-4r util para el tratamiento o la prevencion del asma
MX2023006546A (es) Metodos para la expansion selectiva de poblaciones de celulas t gama y composiciones de estas.
MX2018002301A (es) Composiciones de glucano y usos de las mismas.
MX2022001755A (es) Compuestos de dinucleotidos ciclicos y metodos de uso.
MX2017013564A (es) Formulaciones de glucopiranosil lipido a y alérgenos de cacahuete para administración sublingual.
MX2013004817A (es) Enfermedad inflamatoria.
EP4545639A3 (en) Engineered gamma delta t-cells
PH12015500274B1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
MX2021008113A (es) Composiciones farmaceuticas que comprenden un antagonista de il-4r para usarse en el tratamiento del asma.
MY188139A (en) Sodium channel modulators for the treatment of pain
PH12015500713B1 (en) Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases
IN2013MU03583A (es)
MX2018010032A (es) Formulaciones de antagonista de il-6 y sus usos.
UA114286C2 (uk) Спосіб лікування staphylococcus aureus
ZA201701000B (en) Attenuated bovine coronavirus and related vaccines
MX364800B (es) Tilmicosina de accion prolongada mejorada y el uso de la misma en el tratamiento del complejo respiratorio bovino (crb) y en el periodo de la vaca seca.
GB201302343D0 (en) Pharmaceutical compositions comprising 15-OHEPA and methods for using the same
EP4321218A3 (en) Cancer stem cell targeted cancer vaccines
MX2013003245A (es) Vacuna contra virus de diarrea viral de bovinos.
UA118474C2 (uk) (s)-пірліндол та його фармацевтично прийнятні солі для застосування в медицині
WO2014100857A8 (en) Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy
PH12015502564B1 (en) Pyridone derivatives for the treatment of viral infections and further diseases
MX2021003908A (es) Polipeptidos de accion prolongada y metodos para su produccion y administracion.
MX2016009464A (es) Composiciones para el uso en el tratamiento de afecciones alergicas.
MX2016002930A (es) Moduladores del receptor x hepatico (lxr).